What are the adverse effects of sumatriptan?

Sumatriptan Adverse Effects

Sumatriptan is generally well tolerated, with the most common adverse effects being transient and mild, including chest pressure/heaviness, nausea, dizziness, tingling/numbness, and injection site reactions (for subcutaneous administration), though serious cardiovascular events occur rarely at approximately 1 in 100,000 treated attacks. 1

Common Adverse Effects by Route of Administration

Oral Sumatriptan

• Nausea, vomiting, malaise, and fatigue are the most frequently reported adverse effects 1, 2
• Dizziness, drowsiness, and weakness occur commonly 1, 3
• Tingling or numbness in fingers or toes 3
• Warm or cold sensations 3
• Pain, discomfort, or stiffness in neck, throat, jaw, or chest 3

Subcutaneous Sumatriptan

• Injection site reactions occur in 10-40% of patients 2
• Chest pressure and heaviness 1
• Higher frequency of adverse events compared to other routes, with a clear dose-response relationship 4

Intranasal Sumatriptan

• Unpleasant or bitter taste at the back of the mouth occurs frequently 1, 2
• Chest discomfort 1
• Fatigue, dizziness, and paresthesia 1

Serious Adverse Effects (Rare but Important)

Cardiovascular Events

Serious cardiovascular adverse events are rare but potentially life-threatening, occurring in approximately 0.14% of patients treated with sumatriptan. 2

• Myocardial infarction - case reports exist, including in a 14-year-old male 3, 5, 6
• Coronary vasospasm due to the drug's mechanism of action as a vasoconstrictor 1, 6
• Cardiac arrhythmias, including ventricular tachycardia or fibrillation 1
• Chest discomfort, tightness, pain, pressure, or heaviness - patients should seek emergency care if these symptoms persist 3

Cerebrovascular Events

• Stroke has been reported in postmarketing surveillance 3, 5
• Adverse cerebrovascular events 1

Peripheral Vascular Events

• Raynaud's syndrome - changes in color or sensation in fingers and toes 3
• Peripheral vascular ischemia with symptoms including cramping/pain in legs, heaviness in leg muscles, burning/aching in feet, numbness/tingling/weakness in legs, cold feeling or color changes in extremities 3

Gastrointestinal Ischemic Events

• Gastrointestinal and colonic ischemia with symptoms including sudden/severe stomach pain, stomach pain after meals, weight loss, bloody diarrhea, fever 3

Neurological Events

• Seizures have occurred in patients taking sumatriptan, even in those with no prior seizure history 3
• Visual loss reported in postmarketing experience 3

Serotonin Syndrome

Serotonin syndrome is a rare but serious complication, particularly when sumatriptan is combined with SSRIs or SNRIs. 3

Symptoms include:

• Mental changes (hallucinations, agitation, coma) 3
• Fast heartbeat and blood pressure changes 3
• High body temperature 3
• Tight muscles and trouble walking 3
• Seizures 3

Medication Overuse Headache

Patients who use too many sumatriptan tablets may develop worse headaches (medication overuse headache), potentially requiring discontinuation of therapy. 3

Dose and Route-Related Patterns

Adverse events demonstrate a clear dose-response relationship, with higher doses (100 mg oral) associated with more frequent adverse effects than lower doses (25-50 mg). 1, 4

Subcutaneous administration produces the highest frequency of adverse events but also the most rapid and effective pain relief. 7, 2

Critical Contraindications

Sumatriptan should never be used in patients with:

• Ischemic vascular conditions, vasospastic coronary disease, or significant cardiovascular disease 1
• Uncontrolled hypertension 1
• History of stroke or transient ischemic attacks 3
• Hemiplegic or basilar migraine 1, 3
• Severe hepatic impairment 3
• Within 24 hours of ergotamine derivatives or other triptans 1, 3
• Concurrent use with MAOIs 1, 3

Special Populations

Pregnancy and Lactation

• Should only be used during pregnancy if potential benefit justifies potential risk to fetus 3
• Sumatriptan is excreted in breast milk; infant exposure can be minimized by avoiding breastfeeding for 12 hours after treatment 3

Perioperative Considerations

According to the Society for Perioperative Assessment and Quality Improvement (SPAQI), triptans should be held on the day of surgery due to theoretical concerns about drug-drug interactions and serotonin syndrome risk with perioperative medications. 1

Clinical Pitfalls to Avoid

• Do not prescribe to patients with cardiovascular risk factors without appropriate cardiovascular evaluation 1, 3
• Avoid in patients taking SSRIs/SNRIs without counseling about serotonin syndrome risk, though the actual risk is low 1, 3
• Monitor for medication overuse headache in patients using sumatriptan frequently 3
• Educate patients to seek immediate emergency care for persistent chest symptoms or signs of stroke/MI 3